☰

Judit Papay, Ph.D. - Publications

Affiliations: 
2009 Semmelweis Egyetem, Hungary 
Area:
Oncology
Tree Info Grants Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Szalai F, Sztankovics D, Krencz I, Moldvai D, Pápay J, Sebestyén A, Khoor A. Rictor-A Mediator of Progression and Metastasis in Lung Cancer. Cancers. 16. PMID 38339294 DOI: 10.3390/cancers16030543  0.407
2022 Sugár S, Bugyi F, Tóth G, Pápay J, Kovalszky I, Tornóczky T, Drahos L, Turiák L. Proteomic Analysis of Lung Cancer Types-A Pilot Study. Cancers. 14. PMID 35681609 DOI: 10.3390/cancers14112629  0.459
2021 Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, et al. EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study. Translational Lung Cancer Research. 10: 662-674. PMID 33718012 DOI: 10.21037/tlcr-20-814  0.481
2020 Sarkadi B, Meszaros K, Krencz I, Canu L, Krokker L, Zakarias S, Barna G, Sebestyen A, Papay J, Hujber Z, Butz H, Darvasi O, Igaz P, Doczi J, Luconi M, et al. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. Cancers. 12. PMID 32150977 DOI: 10.3390/Cancers12030599  0.385
2019 Krencz I, Sebestyen A, Papay J, Lou Y, Lutz GF, Majewicz TL, Khoor A. Correlation between immunohistochemistry and RICTOR FISH amplification in small cell lung carcinoma. Human Pathology. PMID 31454632 DOI: 10.1016/J.Humpath.2019.08.018  0.488
2019 Petővári G, Dankó T, Krencz I, Hujber Z, Rajnai H, Vetlényi E, Raffay R, Pápay J, Jeney A, Sebestyén A. Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells. Pathology Oncology Research : Por. PMID 31187466 DOI: 10.1007/S12253-019-00677-2  0.365
2018 Krencz I, Sebestyen A, Papay J, Jeney A, Hujber Z, Burger CD, Keller CA, Khoor A. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis. Human Pathology. PMID 29885404 DOI: 10.1016/J.Humpath.2018.05.018  0.402
2017 Fabian K, Gyulai M, Furák J, Várallyay P, Jäckel M, Bogos K, Dome B, Pápay J, Tímár J, Szallasi Z, Moldvay J. P2.03b-005 Correlation between Primary Tumor Location and Brain Metastasis Development or Peritumoral Brain Edema in Lung Cancer: Topic: Brain Meta Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1286  0.546
2016 Krencz I, Sebestyén A, Fábián K, Márk Á, Moldvay J, Khoor A, Kopper L, Pápay J. Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinoma. Human Pathology. PMID 28025080 DOI: 10.1016/J.Humpath.2016.12.012  0.522
2016 Fábián K, Gyulai M, Furák J, Várallyay P, Jäckel M, Bogos K, Döme B, Pápay J, Tímár J, Szállási Z, Moldvay J. Significance of Primary Tumor Location and Histology for Brain Metastasis Development and Peritumoral Brain Edema in Lung Cancer. Oncology. PMID 27562339 DOI: 10.1159/000447517  0.56
2015 Podmaniczky E, Fábián K, Pápay J, Puskás R, Gyulai M, Furák J, Tiszlavicz L, Losonczy G, Tímár J, Moldvay J. Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer. Pathology Oncology Research : Por. 21: 423-31. PMID 25194563 DOI: 10.1007/S12253-014-9839-X  0.617
2014 Fábián K, Németh Z, Furák J, Tiszlavicz L, Pápay J, Krenács T, Tímár J, Moldvay J. Protein expression differences between lung adenocarcinoma and squamous cell carcinoma with brain metastasis. Anticancer Research. 34: 5593-7. PMID 25275061  0.428
2014 Moldvay J, Pápay J, Kovalszky I, Balázs G, Puskás R, Losonczy G. [Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission]. Magyar Onkologia. 58: 133-7. PMID 25010762  0.376
2012 Galffy G, Bartusek D, Cseh A, Papp V, Zelenak E, Sutto Z, Papay J, Vasarhelyi B, Losonczy G. Effector and regulator T lymphocytes in late stages of non small cell lung cancer and chronic obstructive pulmonary disease Lung Cancer. 77. DOI: 10.1016/J.Lungcan.2012.05.037  0.389
2011 Moldvay J, Pápay J, Puskás R, Furák J, Losonczy G, Matolcsy A. [Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy]. Magyar Onkologia. 55: 105-9. PMID 21655476  0.525
2011 Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Babos F, Magyar A, Géher P, Buzás EI, Nagy G. Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production. International Immunology. 23: 405-14. PMID 21602177 DOI: 10.1093/Intimm/Dxr026  0.455
2011 Baka Z, Barta P, Losonczy G, Krenács T, Pápay J, Szarka E, Sármay G, Magyar A, Buzás E, Falus A, Nagy G. Increased serum PAD4 and RF in lung cancer is not associated with anti CCP antibody production Annals of the Rheumatic Diseases. 70. DOI: 10.1136/Ard.2010.149096.9  0.401
2009 Pápay J, Sápi Z, Egri G, Gyulai M, Szende B, Losonczy G, Tímár J, Moldvay J. Platinum-based chemotherapy in lung cancer affects the expression of certain biomarkers including ERCC1. Pathology Oncology Research : Por. 15: 445-50. PMID 19253035 DOI: 10.1007/S12253-009-9155-Z  0.629
2009 Moldvay J, Sapi Z, Egri G, Gyulai M, Szende B, Losonczy G, Timar J, Papay J. 62P Platinum-Based Chemotherapy In Lung Cancer Affects The Expression Of Certain Biomarkers Including Ercc Lung Cancer. 64. DOI: 10.1016/S0169-5002(09)70185-0  0.631
2008 Pinter F, Papay J, Almasi A, Sapi Z, Szabo E, Kanya M, Tamasi A, Jori B, Varkondi E, Moldvay J, Szondy K, Keri G, Dominici M, Conte P, Eckhardt S, et al. Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry. The Journal of Molecular Diagnostics : Jmd. 10: 160-8. PMID 18258923 DOI: 10.2353/Jmoldx.2008.070125  0.413
2007 Papay J, Krenacs T, Moldvay J, Stelkovics E, Furak J, Molnar B, Kopper L. Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 19-30. PMID 17536303 DOI: 10.1097/01.Pai.0000213143.32030.F5  0.569
2005 Schwab R, Peták I, Pintér F, Szabó E, Kánya M, Tamási A, Várkondi E, Almási A, Szokolóczi O, Pápay J, Moldvay J, Kéri G, Kopper L. [Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma]. Orvosi Hetilap. 146: 2335-42. PMID 16370245  0.314
1990 Lapis K, Pápay J, Paku S. Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice. Oncology. 47: 359-364. PMID 2367062 DOI: 10.1159/000226848  0.385
Show low-probability matches.